Cleared Traditional

K231539 - pRESET LITE Thrombectomy Device (FDA 510(k) Clearance)

Oct 2023
Decision
144d
Days
Class 2
Risk

K231539 is an FDA 510(k) clearance for the pRESET LITE Thrombectomy Device. This device is classified as a Neurovascular Mechanical Thrombectomy Device For Acute Ischemic Stroke Treatment (Class II - Special Controls, product code POL).

Submitted by Phenox Limited (Galway, IE). The FDA issued a Cleared decision on October 21, 2023, 144 days after receiving the submission on May 30, 2023.

This device falls under the Neurology FDA review panel. Regulated under 21 CFR 882.5600. A Neurovascular Mechanical Thrombectomy Device For Acute Ischemic Stroke Treatment Is A Prescription Device Used In The Treatment Of Acute Ischemic Stroke To Improve Clinical Outcomes. The Device Is Delivered Into The Neurovasculature With An Endovascular Approach, Mechanically Removes Thrombus From The Body, And Restores Blood Flow In The Neurovasculature..

Submission Details

510(k) Number K231539 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 30, 2023
Decision Date October 21, 2023
Days to Decision 144 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF

Device Classification

Product Code POL - Neurovascular Mechanical Thrombectomy Device For Acute Ischemic Stroke Treatment
Device Class Class II - Special Controls
CFR Regulation 21 CFR 882.5600
Definition A Neurovascular Mechanical Thrombectomy Device For Acute Ischemic Stroke Treatment Is A Prescription Device Used In The Treatment Of Acute Ischemic Stroke To Improve Clinical Outcomes. The Device Is Delivered Into The Neurovasculature With An Endovascular Approach, Mechanically Removes Thrombus From The Body, And Restores Blood Flow In The Neurovasculature.